These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 29473585)

  • 1. HIV-associated dementia: Prompt response to zidovudine.
    Hoogland ICM; Portegies P
    Neurol Clin Pract; 2014 Jun; 4(3):263-265. PubMed ID: 29473585
    [No Abstract]   [Full Text] [Related]  

  • 2. The impact of zidovudine on dementia-free survival in a population of HIV-positive men and women on antiretroviral therapy.
    Cornelisse PG; Montessori V; Yip B; Craib KJ; O'Shaughnessy MV; Montaner JS; Hogg RS
    Int J STD AIDS; 2000 Jan; 11(1):52-6. PubMed ID: 10667902
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human immunodeficiency virus-associated dementia: review of pathogenesis, prophylaxis, and treatment studies of zidovudine therapy.
    Simpson DM
    Clin Infect Dis; 1999 Jul; 29(1):19-34. PubMed ID: 10433561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Presentation and course of AIDS dementia complex: 10 years of follow-up in Amsterdam, The Netherlands.
    Portegies P; Enting RH; de Gans J; Algra PR; Derix MM; Lange JM; Goudsmit J
    AIDS; 1993 May; 7(5):669-75. PubMed ID: 8318174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk of HIV dementia and opportunistic brain disease in AIDS and zidovudine therapy.
    Baldeweg T; Catalan J; Gazzard BG
    J Neurol Neurosurg Psychiatry; 1998 Jul; 65(1):34-41. PubMed ID: 9667558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Review of antiretroviral therapy in the prevention of HIV-related AIDS dementia complex (ADC).
    Portegies P
    Drugs; 1995; 49 Suppl 1():25-31; discussion 38-40. PubMed ID: 7614899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cerebrospinal fluid beta 2-microglobulin in patients with AIDS dementia complex: an expanded series including response to zidovudine treatment.
    Brew BJ; Bhalla RB; Paul M; Sidtis JJ; Keilp JJ; Sadler AE; Gallardo H; McArthur JC; Schwartz MK; Price RW
    AIDS; 1992 May; 6(5):461-5. PubMed ID: 1616651
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cerebrospinal-fluid HIV-1 RNA and drug concentrations after treatment with lamivudine plus zidovudine or stavudine.
    Foudraine NA; Hoetelmans RM; Lange JM; de Wolf F; van Benthem BH; Maas JJ; Keet IP; Portegies P
    Lancet; 1998 May; 351(9115):1547-51. PubMed ID: 10326538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spectrum of antiviral activity and mechanism of action of zidovudine. An overview.
    Furman PA; Barry DW
    Am J Med; 1988 Aug; 85(2A):176-81. PubMed ID: 3044082
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Implementing short-course zidovudine to reduce mother-infant HIV transmission in a large pilot program in Thailand.
    Kanshana S; Thewanda D; Teeraratkul A; Limpakarnjanarat K; Amornwichet P; Kullerk N; Akksilp S; Sereesittipitak V; Mastro TD; Simonds RJ
    AIDS; 2000 Jul; 14(11):1617-23. PubMed ID: 10983649
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Zidovudine for treating AIDS. What physicians need to know.
    Amin NM
    Postgrad Med; 1989 Jul; 86(1):195-6, 201-8. PubMed ID: 2662155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV in the brain: RNA levels and patterns of zidovudine resistance.
    McClernon DR; Lanier R; Gartner S; Feaser P; Pardo CA; St Clair M; Liao Q; McArthur JC
    Neurology; 2001 Oct; 57(8):1396-401. PubMed ID: 11673579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Zidovudine therapy and HIV encephalitis: a 10-year neuropathological survey.
    Gray F; Bélec L; Keohane C; De Truchis P; Clair B; Durigon M; Sobel A; Gherardi R
    AIDS; 1994 Apr; 8(4):489-93. PubMed ID: 8011252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful zidovudine (AZT) treatment in a case of human immunodeficiency virus (HIV)-1-associated dementia complex.
    Sobanski T; Assion HJ; Scholl HP; Höflich G; Laux G
    Biol Psychiatry; 1996 Jun; 39(12):1065-6. PubMed ID: 8780847
    [No Abstract]   [Full Text] [Related]  

  • 15. Reduced frequency of HIV-induced brain lesions in AIDS patients treated with zidovudine.
    Vago L; Castagna A; Lazzarin A; Trabattoni G; Cinque P; Costanzi G
    J Acquir Immune Defic Syndr (1988); 1993 Jan; 6(1):42-5. PubMed ID: 8417173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of risk group and zidovudine therapy on the development of HIV encephalitis and cognitive impairment in AIDS patients.
    Bell JE; Donaldson YK; Lowrie S; McKenzie CA; Elton RA; Chiswick A; Brettle RP; Ironside JW; Simmonds P
    AIDS; 1996 May; 10(5):493-9. PubMed ID: 8724040
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacotherapy of HIV dementia.
    Melton ST; Kirkwood CK; Ghaemi SN
    Ann Pharmacother; 1997 Apr; 31(4):457-73. PubMed ID: 9101009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Meta-analysis of five randomized controlled trials comparing continuation of zidovudine versus switching to didanosine in HIV-infected individuals.
    Raboud JM; Montaner JS; Rae S; Kahn J; Hammer SM; Katzenstein DA; Pavia A; Dolin R; Hughes MD; Cross A; Beltangady M; Gatell J; Dunkle L; Smaldone L
    Antivir Ther; 1997 Dec; 2(4):237-47. PubMed ID: 11327443
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of zidovudine on cerebrospinal fluid in patients with HIV infection and acute neurological disease.
    Hagberg L; Andersson M; Chiodi F; Fuchs D; Svennerholm B; Wachter H; Norkrans G
    Scand J Infect Dis; 1991; 23(6):681-5. PubMed ID: 1815328
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic effects of nucleoside analogues on psychomotor slowing in HIV infection.
    Arendt G; von Giesen HJ; Hefter H; Theisen A
    AIDS; 2001 Mar; 15(4):493-500. PubMed ID: 11242146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.